Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Complex Kidney Stone PCNL
NCT02966236Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in nephrolithiasis and staghorn calculus, sponsored by Universidade de São Paulo. Primary endpoint: Blood Transfusion Rate at 180 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
nephrolithiasisstaghorn calculus
Beyond the preview
Go deeper on NCT02966236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966236.